Symbolbild · KI-generiert
CryoPort, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
CryoPort provides temperature-controlled logistics solutions for the life sciences, in particular for the transport of cell and gene therapy products and biological materials. The company supplies cryogenic packaging, monitoring technology and supply chain services.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| CryoPort, Inc. | CYRX | NASDAQ | 761 Mio. USD |
| Design Therapeutics, Inc. | DSGN | NASDAQ | 761 Mio. USD |
| Anteris Technologies Global Corp. | AVR | NASDAQ | 763 Mio. USD |
| SpyGlass Pharma, Inc. | SGP | NASDAQ | 753 Mio. USD |
| CCL Industries Inc. Unlimited Class A Voting Shares | CCL.A | TSX | 774 Mio. USD |
| SI-BONE, Inc. | SIBN | NASDAQ | 788 Mio. USD |
| Candel Therapeutics, Inc. | CADL | NASDAQ | 733 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.